Literature DB >> 19459130

Flow cytometry as a tool in the diagnosis of Bernard-Soulier syndrome in Brazilian patients.

Miriam P Beltrame1, M Malvezzi, J Zanis, R Pasquini.   

Abstract

Bernard-Soulier Syndrome (BSS) is an inherited recessive bleeding disorder. In some instances, diagnosis might be restricted to routine blood exams, including bleeding time, prothrombin time (PT), and partial thromboplastin time (APTT). Exams such as platelet aggregation, and testing for expression of ristocetin cofactor, or von Willebrand factor may not be commonly performed. This leads to misdiagnosis in a number of patients, which are subsequently treated erroneously. Flow cytometry has been used widely as a tool in the diagnosis of leukemias, lymphomas, and many other immuno-hematological diseases. The purpose of this study was to assess whether flow cytometry could be helpful in the diagnosis of Bernard-Soulier Syndrome in Brazilian patients. For this, we examined a selected group of 15 patients with suspected BSS based on classical diagnosis. We used a panel of antibodies to detect the expression of glycoproteins GPIbalpha, GPIIb, GPIIIa, GPIX, as well as CD9. Abnormalities of GPIb and GPIX were observed in nine of the 15 patients, which included severe reduction of both antigens, of one or the other, or normal levels but weak expression. Strikingly, this abnormality correlated with severely reduced expression of CD9 in all cases. We discuss the implications for flow cytometric diagnosis of BSS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19459130     DOI: 10.1080/09537100902893784

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  1 in total

1.  A GP1BA Variant in a Czech Family with Monoallelic Bernard-Soulier Syndrome.

Authors:  Magdalena Skalníková; Kateřina Staňo Kozubík; Jakub Trizuljak; Zuzana Vrzalová; Lenka Radová; Kamila Réblová; Radka Holbová; Terézia Kurucová; Hana Svozilová; Jiří Štika; Ivona Blaháková; Barbara Dvořáčková; Marie Prudková; Olga Stehlíková; Michal Šmída; Leoš Křen; Petr Smejkal; Šárka Pospíšilová; Michael Doubek
Journal:  Int J Mol Sci       Date:  2022-01-14       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.